Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below:
Don’t miss our session at #EULAR2026, where CAR T experts will discuss the emerging research in “immune reset” concept, and key considerations for B cell–targeted strategies, including patient selection in clinical trials. https://t.co/zdys5jrZ02
Join us at #EULAR2026, as we present new data from our translational research on the correlation between the tyrosine kinase 2 (TYK2) immune pathway and Sjögren’s disease manifestations. Learn more about immune signaling pathways: https://t.co/gmxxLaD3s0
See how we’re advancing targeted protein degradation using three powerful approaches, CELMoD agents, ligand-directed degraders and degrader antibody conjugates, to drive innovation in cancer and beyond: https://t.co/PdvvVw9lbd
#ASCO26#OneBMS
Today at #ASCO26, tune in for results from a large real-world study on the #CART treatment experience for 2L+ #LBCL across FACT and non-FACT centers in the United States.
Share your perspective on bringing CAR T closer to home for patients. https://t.co/TrnnqCza9i
Join us tomorrow at #ASCO26 as Dr. Solange Peters presents Phase 2 results from ROSETTA Lung-02. @peters_solange
Stop by or join the live stream from 1:21–1:27pm CDT. #LungCancer#BioNTech_Group
Join us tomorrow at #ASCO26 as Dr. Tiago Biachi de Castria presents ROSETTA CRC-203 TiP poster. @BiachiTiago
Join the poster session from 9am to 12pm CDT. #GICancer#BioNTech_Group
Breakthroughs in oncology are moving fast—but access is still determining who benefits from them.
On DoctoRx Unscripted, leading oncologists join Dr. Tania Small to explore what it will take to close that gap. Watch the full oncology series now: https://t.co/da0zAsHCVM
Nearly 70% of lung cancers are still diagnosed at an advanced stage, but science is changing what’s possible—giving some patients years of life back. Two leading oncologists join Dr. Tania Small to discuss how more patients can benefit. Watch now: https://t.co/ceclspOKPC
Melanoma incidence continues to rise, affecting diverse age groups. Early detection and awareness are vital for better outcomes.
Hear more about the realities of melanoma: https://t.co/23StsBLKuV
#OneBMS#MelanomaAwarenessMonth
At #ATS2026, we're exploring the pathophysiology of #PulmonaryFibrosis, and the key role the lysophosphatidic acid (LPA-LPA1) pathway plays in epithelial cell injury, inflammation and fibrosis—all of which result in disease progression. Learn more: https://t.co/htgR1Bu8uQ #OneBMS
Endocannabinoids help regulate neuronal signaling. We’re exploring how inhibition of Fatty acid amide hydrolase (FAAH) and Monoacylglycerol lipase (MAGL) may impact endocannabinoid levels in conditions like Alzheimer’s disease. Learn more: https://t.co/rgOtj9wb2B #OneBMS
Wrap up the last day of the #AACR2026 conference by stopping by the poster session to hear Dr. Jaclyn Neely’s presentation of the biomarker analyses from the RELATIVITY 104 trial.
Join the session from 9am to 12pm PST #LungCancer#NSCLC
Stop by the poster session tomorrow, at #AACR2026, to hear Dr. Takekazu Aoyama’s overview of the RELATIVITY 020 clinical trial, with a focus on dose safety and efficacy.
Join the session from 9am to 12pm PST. #SolidTumor
Today at #AACR2026, Dr. Igor Katsyv will present the poster Comparison of MTAP loss by IHC and MTAP homozygous deletion by NGS and DNA FISH.
Stop by the poster session from 2–5pm PST. #CancerGenomics#AssayDevelopment#AACR2026
Our teams are advancing targeted protein degradation leveraging three distinct modalities: CELMoD agents, ligand-directed degraders and degrader antibody conjugates. Explore how we’re driving cancer breakthroughs: https://t.co/sLyIwnbqEj
#AACR26#ScienceFirsthand#OneBMS
At #AACR26, Dr. Tina Cascone will present data from CheckMate 77T, exploring clinical outcomes by genomic markers and ctDNA dynamics in resectable non-small cell lung cancer (#NSCLC). Learn more: https://t.co/JctSJCnTjE
Explore evidence-based management of Alzheimer’s disease psychosis at AAGP 2026. Dr. Amita Patel, MD, will discuss clinical recognition, differential diagnosis, and current and emerging therapeutic approaches.